Is Edison International a buy sell or hold?
The consensus rating for Edison International (EIX) is currently a "Hold," according to an aggregate of recent analyst ratings [1.7.1]. While 30% of analysts recommend buying (including those who rate it a Strong Buy), 40% suggest holding, and 30% predict a Sell or Strong Sell [1.7.1]. Bulls point to its core EPS growth potential and regulatory stability, whereas bears highlight risks like wildfire liabilities and the potential for unfavorable regulatory decisions [1.7.1]. This split in analyst opinion underscores the stock's position as a stable utility utility with specific risk factors, making it a "Hold" for many institutional and retail investors [1.7.1].
Related FAQs
Eisai operates as a research-based global pharmaceutical company that generates its revenue primarily through the discovery, development, and commercialization of prescription therapeutic drugs.
Residential electricity prices in Japan vary significantly across regional utility service areas, household consumption tiers, and seasonal rate adjustments.
Edison International (EIX) has demonstrated strong stock momentum, with a significant year-to-date share price return and high total shareholder return over the past year [1.6.1].
Yes, Edison International's dividend is generally considered safe and reliable, backed by a long history of consistent payments [1.8.1].
Edison International (EIX) is not generally categorized as a "Dividend Aristocrat," which is a specific designation for companies in the S&P 500 that have increased their dividends for at least 25 consecutive years.
As of July 2026, Edison International (EIX) holds a consensus "Hold" rating among financial analysts.
Edison International is often recognized for its role in the utility sector, yet it is not exempt from significant risks.